Although the role of NKG2D in tumor immunity is not to be proven anymore as shown by the multiple studies demonstrating its involvement in NK cell-mediated killing of various cancer cells (63–65), its specific action in the context of HCT has only been scarcely analyzed. This evidence concerns the gene KLRK1 and neoplasm.